How many injections of Abatacept (Enresu) are needed in a month and interpretation of the treatment plan

Abatacept is a selective T cell costimulation inhibitor, used to treat patients with moderately to severely active rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) and some patients with psoriatic arthritis. Its mechanism of action is mainly by blocking T cell activation, reducing inflammatory response and joint destruction, thereby improving patients' joint pain, stiffness and dysfunction.

Abatacept can be administered by either intravenous infusion or subcutaneous injection. Subcutaneous injection is usually once a week, and each dose is adjusted according to body weight. For example, patients weighing less than 60kg are 125mg/weekly, body weight< span>60-100kg is 125mg/weeks, and patients weighing more than 100kg may require higher doses. The intravenous infusion protocol is generally to repeat the infusion every 4 weeks after the initial dose, and each dose is calculated based on body weight (approximately 10mg/kg).

For patients who receive subcutaneous injection once a week, they usually need to inject 4 times a month, with a fixed dose each time to ensure stable drug blood concentration. Patients with intravenous infusion may only need one infusion per month based on a 4-weekly regimen, but there may be additional starting doses in the initial phase. When choosing an injection method, patients should decide on the most suitable solution based on their doctor's recommendations, personal living arrangements, and tolerance.

During the use of abatacept, the dosage and injection interval prescribed by the doctor should be strictly followed, and avoid increasing or decreasing the number of injections at will. In the early stage of treatment, attention should be paid to the risk of infection and allergic reactions, and blood routine, liver and kidney function, and disease activity indicators should be monitored regularly. Correct injection frequency and dosage management can help improve efficacy, reduce side effects, and improve patients' long-term joint function and quality of life.

Reference link:https://www.drugs.com